Heparin-Induced Thrombocytopenia in a Nonthrombocytopenic Patient With Toxic Epidermal Necrolysis Causing Fatal Outcome: Is HIT Still a HIT?

被引:3
作者
Busche, Marc Nicolai [1 ]
Peters, Tina [1 ]
Knobloch, Karsten [1 ]
Vogt, Peter Maria [1 ]
Rennekampff, Hans-Oliver [1 ]
机构
[1] Hannover Med Sch, Dept Plast Hand & Reconstruct Surg, Burn Ctr, D-30625 Hannover, Germany
关键词
MOLECULAR-WEIGHT HEPARIN; ARGATROBAN ANTICOAGULATION; UNFRACTIONATED HEPARIN; ANTIBODIES; THROMBOSIS; PLATELET-FACTOR-4; REPLACEMENT; THERAPY; RISK;
D O I
10.1097/BCR.0b013e3181ac05bf
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
The definition of heparin-induced thrombocytopenia (HIT) has been modified over time; however, most definitions require a relative or absolute thrombocytopenia after exposure to heparin. Therefore, routine platelet count monitoring has been recommended for screening. We present the case of a 26-year-old male patient with toxic epidermal necrolysis who developed a rapid and fatal clinical presentation of HIT, without thrombocytopenia at the time of diagnosis. Because our patient did not present a relative or absolute thrombocytopenia at the time of serological and clinical confirmation of HIT, routine platelet count monitoring failed to detect HIT in our patient. As a result of the here presented case of rapid and fatal HIT, it may be prudent to consider if thrombocytopenia, although it is still a common and important hallmark of HIT, should be an absolute requirement for the definition of HIT. In cases of HIT without any thrombocytopenia, screening for HIT antibodies may be the only way to detect HIT early enough to react. Because there is a high incidence of HIT antibodies in the general population, which are not always associated with HIT, screening for HIT antibodies cannot be recommended for every patient receiving heparin. However, prospective studies may be useful in determining if routine screening for HIT antibodies can decrease the morbidity and mortality of HIT in critically ill patients receiving therapeutic doses of unfractionated heparin on the intensive care unit. (J Burn Care Res 2009;30: 747-751)
引用
收藏
页码:747 / 751
页数:5
相关论文
共 28 条
[1]   SCORTEN: A severity-of-illness score for toxic epidermal necrolysis [J].
Bastuji-Garin, S ;
Fouchard, N ;
Bertocchi, M ;
Roujeau, JC ;
Revuz, J ;
Wolkenstein, P .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 115 (02) :149-153
[2]   Argatroban anticoagulation in critically ill patients [J].
Beiderlinden, Martin ;
Treschan, Tanja A. ;
Goerlinger, Klaus ;
Peters, Juergen .
ANNALS OF PHARMACOTHERAPY, 2007, 41 (05) :749-754
[3]   Preoperative anti-PF4/heparin antibody level predicts adverse outcome after cardiac surgery [J].
Bennett-Guerrero, E ;
Slaughter, TF ;
White, WD ;
Welsby, IJ ;
Greenberg, CS ;
El-Moalem, H ;
Ortel, TL .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2005, 130 (06) :1567-1572
[4]   Toxic epidermal necrolysis: current evidence, practical management and future directions [J].
Chave, TA ;
Mortimer, NJ ;
Sladden, MJ ;
Hall, AP ;
Hutchinson, PE .
BRITISH JOURNAL OF DERMATOLOGY, 2005, 153 (02) :241-253
[5]   Prevalence of heparin/platelet factor 4 antibodies before and after cardiac surgery [J].
Everett, Brendan M. ;
Yeh, Robert ;
Foo, Shi Yin ;
Criss, David ;
Van Cott, Elizabeth M. ;
Laposata, Michael ;
Avery, Edwin G. ;
Hoffman, William D. ;
Walker, Jennifer ;
Torchiana, David ;
Jang, Ik-Kyung .
ANNALS OF THORACIC SURGERY, 2007, 83 (02) :592-597
[6]   A critical evaluation of assays for detecting antibodies to the heparin-PF4 complex [J].
Francis, JL .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2004, 30 (03) :359-368
[7]   Replacement of unfractionated heparin by low-molecular-weight heparin for postorthopedic surgery antithrombotic prophylaxis lowers the overall risk of symptomatic thrombosis because of a lower frequency of heparin-induced thrombocytopenia [J].
Greinacher, A ;
Eichler, P ;
Lietz, T ;
Warkentin, TE .
BLOOD, 2005, 106 (08) :2921-2922
[8]   Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events [J].
Guerrini, Marco ;
Beccati, Daniela ;
Shriver, Zachary ;
Naggi, Annamaria ;
Viswanathan, Karthik ;
Bisio, Antonella ;
Capila, Ishan ;
Lansing, Jonathan C. ;
Guglieri, Sara ;
Fraser, Blair ;
Al-Hakim, Ali ;
Gunay, Nur Sibel ;
Zhang, Zhenqing ;
Robinson, Luke ;
Buhse, Lucinda ;
Nasr, Moheb ;
Woodcock, Janet ;
Langer, Robert ;
Venkataraman, Ganesh ;
Linhardt, Robert J. ;
Casu, Benito ;
Torri, Giangiacomo ;
Sasisekharan, Ram .
NATURE BIOTECHNOLOGY, 2008, 26 (06) :669-675
[9]  
HACHWUNDERLE V, 1994, LANCET, V344, P469
[10]   Heparin-induced thrombocytopenia and thrombosis: A prospective analysis of the incidence in patients with heart and cerebrovascular diseases [J].
KappersKlunne, MC ;
Boon, DMS ;
Hop, WCJ ;
Michiels, JJ ;
Stibbe, J ;
vanderZwaan, C ;
Koudstaal, PJ ;
vanVliet, HHDM .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 96 (03) :442-446